501371-91-1

Upstream product

• 503859-27-6 methyl 3-amino-4-(cyclohexylamino)benzoate 

Downstream Products

• 480461-26-5 2-[4-(2-bromo-5-nitrobenzyloxy)-2-fluorophenyl]-1-cyclohexyl-1H-benzimidazole-5-carboxylic acid methyl ester 
• 943513-59-5 2-{4-[5-(3-chloropropane-1-sulfonylamino)-2-morpholin-4-ylbenzyloxy]-2-fluorophenyl}-1-cyclohexyl-1H-benzimidazole-5-carboxylic acid methyl ester 
• 943513-66-4 2-[4-(5-chloro-2-morpholin-4-ylbenzyloxy)-2-fluorophenyl]-1-cyclohexyl-1H-benzimidazole-5-carboxylic acid methyl ester 
• 943513-35-7 C₃₃H₃₅FN₄O₆ 
• 943513-56-2 1-cyclohexyl-2-{2-fluoro-4-[2-[(2-methoxyethyl)methylamino]-5-(2-oxopyrrolidin-1-yl)benzyloxy]phenyl}-1H-benzimidazole-5-carboxylic acid methyl ester 
• 943513-34-6 C₃₃H₃₅FN₄O₅ 
• 943513-33-5 C₃₄H₂₉ClFN₃O₆ 
• 943513-55-1 C₃₆H₃₇FN₄O₆ 
• 943513-46-0 C₃₂H₃₃FN₄O₅ 
• 943513-54-0 1-cyclohexyl-2-{2-fluoro-4-[morpholin-4-yl-5-(2-oxopyrrolidin-1-yl)benzyloxy]phenyl}-1H-benzimidazole-5-carboxylic acid methyl ester 
• 943513-29-9 2-{4-[5-(4-chlorobutyrylamino)-2-morpholin-4-ylbenzyloxy]-2-fluorophenyl}-1-cyclohexyl-1H-benzimidazole-5-carboxylic acid methyl ester 

Relevant academic research and scientific papers

NITROGEN-CONTAINING HETEROARYL DERIVATIVES

Disclosed are compounds, compositions and methods for treating Flaviviridae family virus infections.

Fused-ring compounds and use thereof as drugs

The present invention provides a fused ring compound of the following formula [I] wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. Th